AIMM Therapeutics BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AIMM Therapeutics BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011836
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AIMM Therapeutics BV (AIMM Therapeutics) is a biotechnology company that develops progressive approach to the discovery of therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers research programs for prevention and treatment of diseases with medical needs which include cancer, infectious, inflammatory and autoimmune diseases. It sources antibodies from individual patients and a non-human species. The company offers licensing of antibodies and platform licensing services. It partners with research communities and commercial companies for antibody discovery. AIMM Therapeutics is headquartered in Amsterdam, the Netherlands.

AIMM Therapeutics BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AIMM Therapeutics BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
AIMM Acquires IBIS-MX96 System From IBIS Technologies 10
Partnerships 11
AIMM Therapeutics Enters Into Co-Development Agreement With Cosmo Pharma 11
Licensing Agreements 12
Merck Enters into Licensing And Option Agreement with AIMM Therapeutics 12
AIMM Therapeutics BV – Key Competitors 13
AIMM Therapeutics BV – Key Employees 14
AIMM Therapeutics BV – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Key Facts 2
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AIMM Therapeutics BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AIMM Therapeutics BV, Deals By Therapy Area, 2011 to YTD 2017 8
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AIMM Acquires IBIS-MX96 System From IBIS Technologies 10
AIMM Therapeutics Enters Into Co-Development Agreement With Cosmo Pharma 11
Merck Enters into Licensing And Option Agreement with AIMM Therapeutics 12
AIMM Therapeutics BV, Key Competitors 13
AIMM Therapeutics BV, Key Employees 14

★海外企業調査レポート[AIMM Therapeutics BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fluor Corporation (FLR):電力:M&Aディール及び事業提携情報
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • Black Box Corporation (BBOX):企業の財務及び戦略的SWOT分析
    Summary Black Box Corporation (Black Box) formerly ACS Dataline LP is a provider of comprehensive communications and infrastructure solutions. The company’s products include cabinets and racks, cables, datacom, digital signage, industrial, infrastructure hardware, testers and tools, video and multim …
  • SMS Pharmaceuticals Ltd (SMSPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary SMS Pharmaceuticals Ltd (SMS Pharma) is a manufacturer of active pharmaceutical ingredients (APIs) and intermediates that develops offers anti-fungal, anti-ulcer, anti-migraine, anti-hypersensitive, anti-psychotic, anti-viral and other products. Its pipeline products include Ticagrelor, Clop …
  • Marco’s Franchising, LLC:企業の戦略・SWOT・財務分析
    SummaryMarco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Leclanche SA (LECN):企業の財務・戦略的SWOT分析
    Leclanche SA (LECN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dick’s Sporting Goods, Inc.:企業の戦略・SWOT・財務分析
    Dick's Sporting Goods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dick's Sporting Goods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Joyent, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Joyent, Inc. Mergers and Acquis …
  • Ingenuity Systems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ingenuity Systems, Inc. Mergers …
  • JW Holdings Corporation (096760):企業の財務及び戦略的SWOT分析
    Summary JW Holdings Corporation (JW Holdings) is a healthcare company that manufactures medicine. The company research, develops, manufactures, wholesales, and retails medical supplies and instruments. It offers curing medical supplies, I.V. solutions, medical materials, healthcare products, and rea …
  • Tangerine Beach Hotels Limited:企業の戦略・SWOT・財務分析
    Tangerine Beach Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Tangerine Beach Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SUPERVALU INC.:企業の戦略・SWOT・財務分析
    SummarySUPERVALU INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • UOB-Kay Hian Holdings Limited:企業の戦略・SWOT・財務分析
    SummaryUOB-Kay Hian Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Baxter International Inc.:企業のM&A・事業提携・投資動向
    Baxter International Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baxter International Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Softcreate Co., Ltd. (3371):企業財務及び戦略的SWOT分析
    Summary Softcreate Co., Ltd. (Softcreate) is a software solution company that provides information technology system integration services. The company operates through its business segments such as system integration, cloud integration and goods sales. Its services include cybozu solutions, Microsof …
  • Kaira Can Company Limited. :企業の戦略・SWOT・財務分析
    SummaryKaira Can Company Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • First Midwest Bancorp, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' First Midwest Bancorp, Inc. Mer …
  • DLF Limited:企業のM&A・事業提携・投資動向
    DLF Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DLF Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Lockheed Martin Corporation:企業の戦略、SWOT、動向分析
    The report is a comprehensive, strategic resource on Lockheed Martin Corporation providing key insights, analysis & information on the company. The initial sections provide a snapshot & overview on the business operations & market positioning of the company while the SWOT framework analyzes the core …
  • dmg world media:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' dmg world media Mergers and Acq …
  • Yes Bank Wealth Management (532648):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Yes Bank Wealth Management" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆